MOGAT3
2-acylglycerol O-acyltransferase 3
Also known as: DC7, DGAT2L2, MGAT3, MOGT3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86VF5
- Gene
- MOGAT3
- Ensembl
- ENSG00000106384
- Chromosome
- 7
- Canonical length
- 341 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted membrane proteins
OverviewNCBI Gene
Acyl-CoA:monoacylglycerol acyltransferase (MOGAT; EC 2.3.1.22) catalyzes the synthesis of diacylglycerol from 2-monoacylglycerol and fatty acyl-CoA (Cheng et al., 2003 [PubMed 12618427]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
341 residues, UniProt reviewed canonical sequence.
>Q86VF5|MOGAT3
1 MGVATTLQPP TTSKTLQKQH LEAVGAYQYV LTFLFMGPFF SLLVFVLLFT SLWPFSVFYL
61 VWLYVDWDTP NQGGRRSEWI RNRAIWRQLR DYYPVKLVKT AELPPDRNYV LGAHPHGIMC
121 TGFLCNFSTE SNGFSQLFPG LRPWLAVLAG LFYLPVYRDY IMSFGLCPVS RQSLDFILSQ
181 PQLGQAVVIM VGGAHEALYS VPGEHCLTLQ KRKGFVRLAL RHGASLVPVY SFGENDIFRL
241 KAFATGSWQH WCQLTFKKLM GFSPCIFWGR GLFSATSWGL LPFAVPITTV VGRPIPVPQR
301 LHPTEEEVNH YHALYMTALE QLFEEHKESC GVPASTCLTF ILocalizationUniProt · AlphaFold · HPA
Whether an antibody against MOGAT3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 23 nTPM
- small intestine: 22 nTPM
- liver: 17 nTPM
- colon: 12 nTPM
- rectum: 6.8 nTPM
- appendix: 1.5 nTPM
Single-cell type
- enterocytes: 160 nCPM
- colonocytes: 98 nCPM
- paneth cells: 39 nCPM
- enteric transient amplifying cells: 37 nCPM
- goblet cells: 18 nCPM
- enteric stem cells: 14 nCPM
Immune cell
- neutrophil: 0.8 nTPM
- basophil: 0.7 nTPM
- NK-cell: 0.5 nTPM
- eosinophil: 0.3 nTPM
- naive B-cell: 0.3 nTPM
- classical monocyte: 0.2 nTPM
Brain region
- cerebellum: 6.1 nTPM
- white matter: 5.4 nTPM
- cerebral cortex: 4.8 nTPM
- amygdala: 4.4 nTPM
- hippocampal formation: 4.4 nTPM
- pons: 4.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.66
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.31
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MOGAT3 as an antibody target. Whether an autoantibody or antibody against MOGAT3 could matter depends on whether native MOGAT3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MOGAT3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MOGAT3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...